Maternal understanding of infant diabetes risk: Differential effects of maternal anxiety and depression

Genetics in Medicine

Volumn 8, Issue 10, 2006, Pages 665-670

  Hood, Korey K ^a,e   Johnson, Suzanne Bennett ^b   Baughcum, Amy E ^b   She, Jin Xiong ^c   Schatz, Desmond A ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ANXIETY DISORDER; ARTICLE; DEPRESSION; DIABETES MELLITUS; ETHNOLOGY; FEMALE; FOLLOW UP; GENETIC SCREENING; HUMAN; INFANT; INFANT DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INTERVIEW; MAJOR CLINICAL STUDY; MATERNAL DISEASE; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT;

EID: 33750543782     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gim.0000237794.24543.4d     Document Type: Article

References (23)

1. Hattersley AT. Genes versus environment in insulin-dependent diabetes: the phoney war. Lancet 1997;349:147-148.
2. Sadeharju K, Knip M, Hiltunen M, Akerblom HK, et al. The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 2003;46:1100-1105.
3. Morales AE, She JX, Schatz DA,. Prediction and prevention of type 1 diabetes. Curr Diab Rep 2001;1(1):28-32.
4. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-229.
5. Knip M. Prediction and prevention of type 1 diabetes. Acta Paediatr Suppl 1998;425:54-62.
6. Rewers M, Bugawan TL, Norris JM, Blair A, et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 1996;39:807-812.
7. Ziegler AG, Hummel M, Schenker M, Bonifaco E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48:460-469.
8. Berzina L, Shtauvere-Brameus A, Ludvigsson J, Sanjeevi CB. Newborn screening for high-risk human leukocyte antigen markers associated with insulin-dependent diabetes mellitus. Ann NY Acad Sci 2002;958:312-316.
9. Schatz D, Muir A, Fuller K, Atkinson M, et al. Prospective Assessment in Newborns for Diabetes Autoimmunity (PANDA): a newborn screening program in the general population of Florida. Diabetes 2000;49(Suppl 1):A67.
10. Ross LF. Predictive genetic testing for conditions that present in childhood. Kennedy Inst Ethics J 2002;12 (3):225-244.
11. Almond B. Genetic profiling of newborns: ethical and social issues. Nat Rev Genet 2006;7:67-71.
12. Johnson SB. Screening programs to identify children at risk for diabetes mellitus: psychological impact on children and parents. J Pediatr Endocrinol Metab 2001;14(suppl 1):653-659.
13. Carmichael S, Johnson SB, Baughcum A, North K, et al. Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk. Genet Med 2003;5:77-83.
14. Johnson SB, Baughcum A, Carmichael S, She J-X, et al. Maternal anxiety associated with newborn genetic screening for type 1 diabetes. Diabetes Care 2004;27:392-397.
15. Hood KK, Johnson SB, Carmichael SK, Laffel LMB, et al. Depressive symptoms in mothers of infants identified as genetically at risk for type 1 diabetes. Diabetes Care 2005;28:1898-1903.
16. Johnson SB, Carmichael SK. At risk for diabetes: coping with the news. J Clin Psychol Med Settings 2000;7:69-78.
17. Baughcum AE, Johnson SB, Carmichael SK, Lewin AB, et al. Maternal efforts to prevent type 1 diabetes in at-risk children. Diabetes Care 2005;28:916-921.
18. Yu M, Norris J, Mitchell C, Butler-Simon N, et al. Impact on maternal parenting stress of receipt of genetic information regarding risk of diabetes in newborn infants. Am J Med Genet 1999;86:219-226.
19. Lernmark B, Elding-Larsson H, Hansson G, Lindberg B, et al. Parent responses to participation in genetic screening for diabetes risk. Pediatr Diabetes 2004;5:174-181.
20. Stolt UG, Helgesson G, Liss P-E, Svensson T, et al. Information and informed consent in a longitudinal screening involving children: a questionnaire survey. Eur J Hum Genet 2005;13:376-383.
21. Wang C, Gonzalez R, Merajver SD. Assessment of genetic testing and related counseling services: current research and future directions. Soc Sci Med 2004;58:1427-1442.
22. Spielberger CD, Gorsuch RL, Lushene R. Test Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1970.
23. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.